Abstract:Drug-Drug Interaction (DDI) refers to the combined effects that occur when a patient takes multiple medications simultaneously or within the same period. This interaction can either enhance the therapeutic effects of the drugs or inhibit their efficacy, and in severe cases, it can even lead to adverse drug reactions (ADRs). Thus, it is crucial to identify potential DDIs, as this information is significant for both biological research and clinical medicine. However, most existing works only consider the information of individual drugs or focus on the local correlation between a few medical entities, thus overlooking the global performance of the entire human medical system and the potential synergistic effects of multi-scale information. Consequently, these limitations hinder the predictive ability of models. In this paper, we propose an innovative multi-scale feature fusion model called ALG-DDI, which can comprehensively incorporate attribute information, local biological information, and global semantic information. To achieve this, we first employ the Attribute Masking method to obtain the embedding vector of the molecular graph. Next, ALG-DDI leverages heterogeneous graphs to capture the local biological information between drugs and several highly related biological entities. The global semantic information is also learned from the medicine-oriented large knowledge graphs. Finally, we employ a transformer encoder to fuse the multi-scale drug representations and feed the resulting drug pair vector into a fully connected neural network for prediction. Experimental evaluations on datasets of varying sizes and different classification tasks demonstrate that ALG-DDI outperforms other state-of-the-art models.

A multi-task graph convolutional network modeling of drug-drug interactions and synergistic efficacy

Graph-augmented Convolutional Networks on Drug-Drug Interactions Prediction

Predicting drug–drug interactions by graph convolutional network with multi-kernel

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

Multi-type feature fusion based on graph neural network for drug-drug interaction prediction

SMGCN: Multiple Similarity and Multiple Kernel Fusion Based Graph Convolutional Neural Network for Drug-Target Interactions Prediction.

Prediction of Drug-Drug Interaction Using an Attention-Based Graph Neural Network on Drug Molecular Graphs

Drug-drug Interaction Prediction with Graph Representation Learning

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

DRUGSYNC: Prediction of Synergistic Drug Combinations Using GCN Graph Convolutional Network based and Pre-learned Drug-induced Gene Expression Profiles

CNN-DDI: a learning-based method for predicting drug–drug interactions using convolution neural networks

A multi-scale feature fusion model based on biological knowledge graph and transformer-encoder for drug-drug interaction prediction

A multi-task graph deep learning model to predict drugs combination of synergy and sensitivity scores

Synergizing Convolutional Neural Networks and Drug Similarity Estimation for Improved Drug-Drug Interaction Prediction

DDoS: A Graph Neural Network based Drug Synergy Prediction Algorithm

Integrated Multi-Similarity Fusion and Heterogeneous Graph Inference for Drug-Target Interaction Prediction

Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction

Identifying Drug-Target Interactions Based on Graph Convolutional Network and Deep Neural Network.

An End-to-end Heterogeneous Graph Representation Learning-Based Framework for Drug-Target Interaction Prediction.

Multi-view feature representation and fusion for drug-drug interactions prediction